Phage Therapy: Beyond Antibacterial Action
Data obtained strongly suggest that phages may induce immunomodulatory effects which can be used in the clinic in phagotherapy
Data obtained strongly suggest that phages may induce immunomodulatory effects which can be used in the clinic in phagotherapy
Pseudomonas aeruginosa phage cocktail in a sheep model of rhinosinusitis was able to decrease sinus pathogen biofilm. No safety concerns were noted
Phage therapy constitutes a very promising approach in the control of topical microbial populations
A new study shows that these pathogenic bacteria can be killed cheaply and quickly by a combined treatment with sunlight and bacteria-killing viruses called bacteriophages
Two phage clinical trials will launch in the USA in 2019. The trials will evaluate the safety, tolerability and efficacy of experimental bacteriophage therapy in people with Crohn's disease and VADs infected by resistant S. aureus
Researchers from across disciplines at Charles River discuss which trends they expect will propel the development of novel therapeutics forward this year. Phage Therapy one of the Top 10 Drug Discovery Trends to Watch in 2019
The 3rd Microbiome Movement – Drug Development Europe (28-30 January 2019) returns as the industry-defining forum to help discover, develop and deliver the next generation of microbiome-based therapeutic and diagnostic candidates to market
A nationwide study in Denmark have shown the association between treated infections and the subsequent risk of treated mental disorders in children and adolescent
Phage treatment has high specificity when combating Salmonella infection and offers a noninvasive alternative to antibiotic treatment